/
No Comments
A pharmaceutical research and healthcare setting representing Sun Pharma's agreement with the US government.
A pharmaceutical research and healthcare setting representing Sun Pharma's agreement with the US government.
Key Highlights India is continuing discussions with the United States regarding proposed tariffs under Section 301 of the U.S. Trade Act of 1974 while simultaneously working to finalize a bilateral trade framework agreement. The proposed tariffs are currently under consultation and have not yet been finalized. India remains actively engaged...
What it means for India: Key points Why Section 301 matters Section 301 is a provision of US trade law that allows the US government to investigate foreign trade practices and, if it determines those practices are unfair or harmful to American commerce, impose unilateral trade measures such as additional...
Key Highlights US Defence Secretary Pete Hegseth has praised India’s growing military preparedness and defence modernisation efforts, highlighting New Delhi as one of the key strategic partners contributing to stability in the Indo-Pacific region. Speaking at the prestigious Shangri-La Dialogue 2026 in Singapore, Hegseth said India and several Asian nations...
India Business & Trade is a national media platform decoding the ideas, decisions and shifts shaping India’s growth story—across plicy, business, global commerce and a rapidly evolving marketplace.
India Business & Trade
M-62, Saket, New Delhi-110064, India
Stay ahead in the dynamic world of trade and commerce with India Business & Trade’s weekly newsletter.
Copyright © 2026 India Business & Trade. All Rights Reserved
